181 related articles for article (PubMed ID: 26048403)
1. Copy number alterations and allelic ratio in relation to recurrence of rectal cancer.
Goossens-Beumer IJ; Oosting J; Corver WE; Janssen MJ; Janssen B; van Workum W; Zeestraten EC; van de Velde CJ; Morreau H; Kuppen PJ; van Wezel T
BMC Genomics; 2015 Jun; 16(1):438. PubMed ID: 26048403
[TBL] [Abstract][Full Text] [Related]
2. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
3. Genomic CGH-assessed structural DNA alterations in rectal carcinoma as related to local recurrence following primary operation for cure.
Kodeda K; Asting AG; Lönnroth C; Derwinger K; Wettergren Y; Nordgren S; Gustavsson B; Lundholm K
Int J Oncol; 2012 Oct; 41(4):1397-404. PubMed ID: 22825718
[TBL] [Abstract][Full Text] [Related]
4. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
6. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
7. Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer.
de Maat MF; van de Velde CJ; Benard A; Putter H; Morreau H; van Krieken JH; Meershoek Klein-Kranenbarg E; de Graaf EJ; Tollenaar RA; Hoon DS
Clin Cancer Res; 2010 May; 16(10):2811-8. PubMed ID: 20460484
[TBL] [Abstract][Full Text] [Related]
8. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer.
Bikhchandani J; Ong GK; Dozois EJ; Mathis KL
Dis Colon Rectum; 2015 Mar; 58(3):283-7. PubMed ID: 25664705
[TBL] [Abstract][Full Text] [Related]
10. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
11. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic significance of chromosomal DNA sequence copy number aberrations in patients with colorectal carcinoma].
Liu XP; Kawauchi S; Oga A; Sasaki K
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):355-9. PubMed ID: 17892131
[TBL] [Abstract][Full Text] [Related]
13. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers for recurrence and sensitivity to preoperative chemoradiotherapy in locally advanced rectal tumours.
Romain B; Meyer N; Brigand C; Chenard MP; Schneider A; Guenot D
Dig Surg; 2014; 31(4-5):347-53. PubMed ID: 25503074
[TBL] [Abstract][Full Text] [Related]
15. Gene signature is associated with early stage rectal cancer recurrence.
Kalady MF; Dejulius K; Church JM; Lavery IC; Fazio VW; Ishwaran H
J Am Coll Surg; 2010 Aug; 211(2):187-95. PubMed ID: 20670856
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 activity predicts local recurrence in rectal cancer.
de Heer P; de Bruin EC; Klein-Kranenbarg E; Aalbers RI; Marijnen CA; Putter H; de Bont HJ; Nagelkerke JF; van Krieken JH; Verspaget HW; van de Velde CJ; Kuppen PJ;
Clin Cancer Res; 2007 Oct; 13(19):5810-5. PubMed ID: 17908973
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations predict local recurrences in rectal cancer patients.
He Y; Van't Veer LJ; Mikolajewska-Hanclich I; van Velthuysen ML; Zeestraten EC; Nagtegaal ID; van de Velde CJ; Marijnen CA
Clin Cancer Res; 2009 Nov; 15(22):6956-62. PubMed ID: 19903786
[TBL] [Abstract][Full Text] [Related]
18. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
19. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
20. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
